Medication Use Crisis Sponsored by the VA Medication Reconciliation Initiative In conjunction with VHA Program Offices, DoD and IHS ADEs and RCAs: Reports.

Slides:



Advertisements
Similar presentations
Critical Event Review (Root Cause Analysis)
Advertisements

Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
5th Annual PBM Pharmacy Informatics Conference
An Imperative for Performance Improvement
Learning Objectives Understand the Mission of Pharmacy Benefits Management Understand the Background on Pharmacy Re-Engineering Project (PRE) including.
Adverse Drug Events (ADEs)
John Lowe Associate Chief Consultant PBM Why Are We Here?
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
TIGER Standards & Interoperability Collaborative Informatics and Technology in Nursing.
Drug Utilization Review (DUR)
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Medication Reconciliation Insert your hospital’s name here.
[Hospital Name | Presenter name and title | Date of presentation]
Maenne Okunola Pharm D Candidate: University of Georgia June 3, 2012 Preceptor Dr. Ali Rahimi.
Learning about Safe Systems Dr. Maureen Baker CBE DM FRCGP Clinical Director for Patient Safety NHS Connecting for Health.
Centralized Non-Formulary Processing: Implementation of a CPRS “Reminder Dialog Template” Note to Request Restricted Drugs and Utilization of VISN 17 PBM.
Community Care and Wellness for Seniors
by Joint Commission International (JCI)
Presented to [Date] By [Insert Name] The Application of FMEA to a Medication Reconciliation Process.
By Ruth Kavita Senior Pharmaceutical Technologist, KNH.
ProClarity: Practical Applications Thomas R. Emmendorfer, PharmD Assistant Chief Consultant Pharmacy Benefits Management (PBM) Services.
Topic 5 Understanding and learning from error. LEARNING OBJECTIVE Understand the nature of error and how health care can learn from error to improve patient.
1. Infection Control Risk Assessment Terrie B. Lee, RN, MS, MPH, CIC Director, Infection Prevention & Employee Health Charleston Area Medical Center Charleston,
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Clinical Risk Unit University College London International Perspectives Feedback from the review board Charles Vincent Clinical Risk Unit University College.
Responsibilities and Principles of Drug Administration
Increasing Pharmacists reporting of adverse medication incidents Being Ready for new risks and Opportunities Prepared by Tim Garrett Northern Sydney Central.
Prescribing Errors in General Practice The PRACtICe Study (2012) GMC Investigating Prevalence and Causes.
Adverse Drug Event Reporting
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Medication Use Evaluation
Chapter 6 – Data Handling and EPR. Electronic Health Record Systems: Government Initiatives and Public/Private Partnerships EHR is systematic collection.
© 2009 On the CUSP: STOP BSI Identifying Hazards.
PSO Overview for Executives (Presenter) (Date) Center for Patient Safety Toolkit for PSO Participation, Section 4.
Medication Use Process Part One, Lecture # 5 PHCL 498 Amar Hijazi, Majed Alameel, Mona AlMehaid.
The Comprehensive Unit-based Safety Program (CUSP)
DVT Prevention and Anticoagulant Management
ASPECTS AFFECTING THE HOSPITAL OPERATION Financial Financial Operational Operational Administrative Administrative Clinical Clinical Safety Safety.
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
Surgical safety is a serious public health issue About 234 million operations are done globally each year A rate of % deaths and 3-16% complications.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Surgical safety is a serious public health issue About 234 million operations are done globally each year A rate of % deaths and 3-16% complications.
Establishing and Maintaining Effective Safety Committees.
Pharmacists’ Patient Care Process
8 Medication Errors and Prevention.
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
Michela C.C. Fiori, Pharm.D. PGY1 Pharmacy Resident, Penobscot Community Health Care Outcomes of a Pharmacist-Driven Education Program For Residents Discharged.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
ADVERSE DRUG EVENT (ADE) Driver Diagram OHA HEN 2.0.
Documentation in Practice Dept. of Clinical Pharmacy.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
CLINICAL TRIALS.
Governing Body QAPI 2013 Update for ASC
Documentation of pharmaceutical care
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Introduction to Clinical Pharmacy
Air Carrier Continuing Analysis and Surveillance System (CASS)
CITE THIS CONTENT: RYAN MURPHY, “EVENT REPORTING”, ACCELERATE UNIVERSITY OF UTAH HEALTH CURRICULUM, JUNE 1, 2018 (Updated August 24, AVAILABLE AT: 
Provider and Member Education in Managed Care Pharmacy
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Tobey Clark, Director*, Burlington USA
8 Medication Errors and Prevention.
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Presentation transcript:

Medication Use Crisis Sponsored by the VA Medication Reconciliation Initiative In conjunction with VHA Program Offices, DoD and IHS ADEs and RCAs: Reports and insight from the frontline Bruce McIntosh, Pharm.D. Patient Safety Pharmacist VA National Center for Patient Safety Francesca Cunningham, Pharm.D. Associate Chief Consultant Center for Medication Safety and PBM Services

Medication Use Crisis Sponsored by the VA Medication Reconciliation Initiative In conjunction with VHA Program Offices, DoD and IHS ADEs and RCAs: Root Cause Analysis Bruce McIntosh, Pharm.D. Patient Safety Pharmacist VA National Center for Patient Safety

VETERANS ADMINISTRATION PATIENT CARE SERVICES NCPS Background and Root Cause Analysis (RCA) In 1999, the VA National Center for Patient Safety (NCPS) was established to lead the effort to improve the safety of patients cared for in the VA health system To allow facility, network and VHA-wide learning about adverse events, NCPS developed a standardized method for “root cause analysis” (RCA) The RCA process involves the identification of basic or contributing causal factors to adverse events or close calls, and then using that information to develop actions to address the identified causes and prevent harm to patients in the future 2

VETERANS ADMINISTRATION PATIENT CARE SERVICES WHAT is a RCA? 3 Process for identifying contributing/causal factors that underlie variations in performance associated with adverse events or close calls Process that features interdisciplinary involvement of those closest to and/or most knowledgeable about the situation

VETERANS ADMINISTRATION PATIENT CARE SERVICES RCA (The NCPS Model) 4 A rigorous, legally protected, and confidential approach to answering: – What happened? (event or close call) What happened that day? What usually happens? (norms) What should of happened? (policies) – Why did it happen? – What are we going to do to prevent it from happening again? (actions) – How will we know that our actions improved patient safety? (outcomes)

VETERANS ADMINISTRATION PATIENT CARE SERVICES RCA (continued) Whose fault is it? Who do we blame? How did we get here? How do we prevent it from happening again? 5 Questions typically asked in healthcare: Questions typically asked in high reliability organizations:

Physical Plant Design/ Layout 5% Equipment or Software 14% Communication – 24% Training – 11% Policies & Procedures 43% Actions Identified by RCA Teams NA = 3% N = 270 Actions REASON, J. (1997) Managing the risks of organizational accidents, Hampshire, England, Ashgate Publishing Limited.

VETERANS ADMINISTRATION PATIENT CARE SERVICES Root Cause Analysis (RCA) Draft 2012 NCPS analysis of the membership of RCA teams from FY06 through FY11

7,539 26,150 14,997 11,694 21,228 10,070 Barriers11.0% Environment/Equipment12.8% Communication28.5% Fatigue/Scheduling8.2% Training16.4% Rules/Policies/Procedures23.2% Total:100.0% VA Root Cause Analysis (RCA) SPOT Database VA National Center for Patient Safety SPOT Database. Accessed Sept. 22, SPOT Database from ,120 adverse events studied in detail 9,822 reports cite “communication” as a “triage category” for at least one of the root causes. 75% of adverse events have “communication” as a contributing factor.

VETERANS ADMINISTRATION PATIENT CARE SERVICES RCA- Communication Breakdown “Insufficient communication” was the most frequently cited root cause of the nearly 3,000 sentinel events reported to the Joint Commission between 1995 and 2004 Not surprisingly, over 70% of all OR-related sentinel events between 1995 and 2005 cited communication as a root cause 9 Pillars of a Smart, Safe Operating Room,” F. Jacob Seagull, MD; Gerald R. Moses, PhD; Adrian E. Park, MD Retrieved December 16, 2011 from Seagull_98.pdfhttp:// Seagull_98.pdf

VETERANS ADMINISTRATION PATIENT CARE SERVICES Medication Events from RCAs Summary of Root Cause Analyses Event Types (Not Including Aggregate Review Reports) This graph was created on 02/02/12.

VETERANS ADMINISTRATION PATIENT CARE SERVICES Adverse Events and Close Calls 11 Draft 2012 NCPS analysis FY06 through FY11

VETERANS ADMINISTRATION PATIENT CARE SERVICES RCA and Medication Events During fiscal year 2008, NCPS received 232 medication-related Root Cause Analysis (RCA) reports and 181 aggregated review reports covering 20,724 Med events reported in FY 2008 The most common reported Med event was omission (18%) 6,607 Actions were recommended to address the problems 4,832 Actions were implemented to date (73%) 12 Draft 2012 NCPS analysis

VETERANS ADMINISTRATION PATIENT CARE SERVICES NCPS Medication Safety Improvements Insulin U-500 Safety Enhancements VHA Prescription Label Redesign Epinephrine, Phenylephrine, and other High Alert Medication Safety in the OR Standardized Process for Insulin Orders when used in Subcutaneous Implanted Insulin Pumps Anticoagulation Therapy Management Directive OIA Patient Safety Alerts Other examples 13

VETERANS ADMINISTRATION PATIENT CARE SERVICES Examples of Medication Event RCAs from the Frontline Warfarin dosing instructions for new admissions Discharge process and CPRS prescription orders Patient discharged home without IV antibiotics Patient received another patients outpatient medications Non-VA case example (Comparison to VA) 14

VETERANS ADMINISTRATION PATIENT CARE SERVICES Reaching for High Reliability 15 Safety Matters 99.9% Reliability = 20,000 incorrect prescriptions every year 500 incorrect operations each week 1 hour of unsafe drinking water every month 22,000 bank checks deducted from the wrong bank account each hour NCPS Curriculum

Medication Use Crisis Sponsored by the VA Medication Reconciliation Initiative In conjunction with VHA Program Offices, DoD and IHS ADEs and RCAs: Reports and insight from the frontline: Focus on Pharmacovigilance and Drug Surveillance from the National Level Francesca Cunningham, Pharm.D. Associate Chief Consultant Center for Medication Safety and PBM Services

VETERANS ADMINISTRATION PATIENT CARE SERVICES OVERVIEW Overview of VAMedSAFE Goals Surveillance and Monitoring – VA ADERS – Database Surveillance Risk Reduction Efforts and Assessment Brief Overview of MUET System 17

VETERANS ADMINISTRATION PATIENT CARE SERVICES GOAL of VA PHARMACOVIGILANCE PROGRAM - VAMedSAFE Track and evaluate high risk and high volume agents in Veteran population Determine rates and risks of ADEs associated with specific agents Maintain the national drug safety program with emphasis on: – Utilizing integrated databases as the foundation of the VA pharmacovigilance program – Enhancing spontaneous ADE reporting for system based changes and enhancement of drug safety efforts – Communicating drug safety information

VETERANS ADMINISTRATION PATIENT CARE SERVICES Adverse Drug Events in VA Reporting, Tracking, Monitoring Adverse Drug Event Database (VA ADERS) – Spontaneous Reporting Adverse Drug Event Tracking and Evaluation Using VA Integrated Databases – Prescription Databases – Inpatient/Outpatient Files

VETERANS ADMINISTRATION PATIENT CARE SERVICES EXAMPLE OF VA ADERS 20

VETERANS ADMINISTRATION PATIENT CARE SERVICES VA ADERS NATIONAL DATABASE Program Goals Standardized reporting – To VA, FDA MedWATCH and FDA VAERS (vaccines) Centralized – Database contains records on 284,587 Reports and 403,125 symptoms (through April 17, 2012) Tracking and Trending reports Web-based reporting >> 3761 Reporters at 150 facilities in 22 VISNs (21 VISNs plus CMOP) Surveillance and Benchmarking Process Improvements

VETERANS ADMINISTRATION PATIENT CARE SERVICES American Journal of Health-System Pharmacy February 15, 2012 vol. 69 no

VETERANS ADMINISTRATION PATIENT CARE SERVICES Recent activity in VA ADERS Report selection for: – Drug: all ADRs/ADEs to drugs, biologics to be reported to VA and when appropriate/required FDA MedWATCH – Vaccine: all events with immunizations to be reported to FDA Vaccine Adverse Event Reporting System (VAERS) Monitoring – contributions to overall surveillance activities

VETERANS ADMINISTRATION PATIENT CARE SERVICES Monitoring Past – Heparin – Cholinesterase Inhibitors – Venlafaxine – Spironolactone/Eplerenone – Iron Dextran Current – Vaccines (Influenza) – Varenicline – Dabigatran – Dronedarone – Sentinel events (fatal outcomes) – Niacin Conversion Key element to all monitoring: Reporting from Health Care Practitioners Reporter OccupationReport CountReporter OccupationReport Count NURSE466PHYSICIAN ASSISTANT48 NURSE PRACTITIONER112PROVIDER4,245 OTHER20,364QUALITY MGT1,079 PHARMACIST257,780RADIOLOGY11 PHYSICIAN482

VETERANS ADMINISTRATION PATIENT CARE SERVICES ADR Recognition and Reporting Recognizing and documenting ‘observed’ events Increase the “known” reactions – Increases the total of reported reactions Increases opportunity for event EVALUATION – Reporting to FDA MedWATCH program Strengthens Pharmacovigilance efforts

VETERANS ADMINISTRATION PATIENT CARE SERVICES VA ADERS Program Focus – Closing the Gap Close the GAP between events that occur and the events that are reported. How? – ARTS Draft Imports process – Educate about ‘Observed’ events – Educate reporters – Educate providers – Educate patients Improve patient safety Increase Reporting!

VETERANS ADMINISTRATION PATIENT CARE SERVICES Surveillance in VA The VA as a resource for active surveillance and adverse event evaluation – Older/Sicker patients – High medication use – Good Information Systems

VETERANS ADMINISTRATION PATIENT CARE SERVICES PHARMACOVIGILANCE AND DRUG SURVEILLANCE USING INTEGRATED DATABASES SELECTED EXAMPLES OF VAMedSAFE PHARMACOVIGILANCE / SURVEILLANCE PROJECTS – Antipsychotics – TZDs – High Dose Statins – PPIs – Opioids – Dronedarone – Dabigatran – Vaccines 28

EXAMPLES

Surveillance, Evaluation and Formulary Decision Rapid Cycle Evaluation was developed and completed and results served as a preliminary marker for full pharmacoepidemiologic study Subsequent analysis was designed and conducted - - Formulary Decision Detailed analysis using Registry data and more sophisticated analytic methods conducted

Consistent with VA Criteria for Use, rosiglitazone and pioglitazone were most commonly prescribed as 3rd line agents Health risk for rosiglitazone did not support the high percentage level identified in the meta analysis A slight but consistently lower risk was found for pioglitazone compared to rosiglitazone particularly when rosiglitazone was used as third line agent or in combination with insulin CONCLUSION

VETERANS ADMINISTRATION PATIENT CARE SERVICES VA Decision Rosiglitazone was removed from Formulary but remained available in the VA healthcare system Pioglitazone became VA’s preferred TZD Criteria for Drug Use updated

VETERANS ADMINISTRATION PATIENT CARE SERVICES Dronedarone Patients prescribed dronedarone through 2 nd quarter of fiscal year 2011 – # patients exposed Evaluation – Inappropriate prescribing in HF pts – Exacerbation of HF – New Onset HF

Dronedarone All users Dronedarone Incident UsersHF Dx Post Dronedarone Initiation Evaluation period: Cohort within 30 days N(%) within 90 days N(%) within 180 days N(%) No Hx of HF Mild Heart Failure Recent Decompensated HF (Risk Reduction)

Risk Reduction and Intervention Assessment Risk Reduction Program was initiated to: – Identify patients receiving medications with a true contraindication for a given disease state or patients requiring a change in medication regimen to enhance patient safety and prevent potential untoward outcomes. Intervention Assessment – Evaluation designed to assess the outcome of a specific intervention (ie, safety intervention, formulary decision)

VETERANS ADMINISTRATION PATIENT CARE SERVICES Risk Reduction Projects (Selected Example) Nifedipine (short Acting) – Prototype High Dose Vitamin E Alpha Blocker Monotherapy LABA Monotherapy Ketoconazole/Simvastatin High Dose Zolpidem Glyburide in Elderly with RI

VETERANS ADMINISTRATION PATIENT CARE SERVICES Glyburide Risk Reduction

VETERANS ADMINISTRATION PATIENT CARE SERVICES Glyburide Intervention Assessment Goal – To assess outcomes secondary to intervention Outcomes – Glycemic Control – Severe Hypoglycemia – Subgroup Analysis (severe RI)

VETERANS ADMINISTRATION PATIENT CARE SERVICES Glyburide Intervention Assessment Results

VETERANS ADMINISTRATION PATIENT CARE SERVICES Glyburide Intervention Assessment Conclusions The Risk Reduction successfully switched high-risk patients to safer medication alternatives Glycemic control was not significantly impacted Lower rates of severe hypoglycemia in patients at greatest risk (e.g. sCr > 2.9)

VETERANS ADMINISTRATION PATIENT CARE SERVICES MUE PROCESS 41

VETERANS ADMINISTRATION PATIENT CARE SERVICES MEDICATION USE EVALUATION TRACKER (MUET) MUET Users 336 Sites (Parent facilities, CBOCs, etc) 21 VISNs

VETERANS ADMINISTRATION PATIENT CARE SERVICES MUET is Flexible One access point… -Standard format for recording information and interventions across all facilities -Diverse: Each initiative has its own criteria, interventions

VETERANS ADMINISTRATION PATIENT CARE SERVICES MUET – Criteria and Goals Glyburide Criteria 1. Patients with active glyburide 2. Age > 65 and serum creatinine > 2.0 mg/dl Program GOALS Identify high risk patients Provide secure list to sites Trigger opportunity for interventions Track interventions Overall Risk Reduction

VETERANS ADMINISTRATION PATIENT CARE SERVICES Feedback from MUET Users MUET is a Useful Tool to:  Identify high risk patients needing intervention (increased patient safety)  Operationalize prescribing protocol  Document interventions and workload  Increase awareness of pharmacy managed monitoring service  Benchmark facilities with management programs vs. facilities without  Meet JC requirements

VETERANS ADMINISTRATION PATIENT CARE SERVICES QUESTIONS 46